4.8 Article

Sperm from Sneaker Male Squids Exhibit Chemotactic Swarming to CO2

Journal

CURRENT BIOLOGY
Volume 23, Issue 9, Pages 775-781

Publisher

CELL PRESS
DOI: 10.1016/j.cub.2013.03.040

Keywords

-

Funding

  1. Narishige Zoological Science Award
  2. Research Institute of Marine Invertebrates
  3. Yamada Science Foundation
  4. Ministry of Education, Culture, Sports, Science and Technology, Japan
  5. Japanese Association for Marine Biology
  6. Grants-in-Aid for Scientific Research [21112004, 10J07243, 25440102] Funding Source: KAKEN

Ask authors/readers for more resources

Behavioral traits of sperm are adapted to the reproductive strategy that each species employs. In polyandrous species, spermatozoa often form motile clusters, which might be advantageous for competing with sperm from other males [1]. Despite this presumed advantage for reproductive success [2, 3], little is known about how sperm form such functional assemblies. Previously, we reported that males of the coastal squid Loligo bleekeri produce two morphologically different euspermatozoa that are linked to distinctly different mating behaviors [4]. Consort and sneaker males use two distinct insemination sites, one inside and one outside the female's body, respectively. Here, we show that sperm release a self-attracting molecule that causes only sneaker sperm to swarm. We identified CO2 as the sperm chemoattractant and membrane-bound flagellar carbonic anhydrase as its sensor. Downstream signaling results from the generation of extracellular H+, intracellular acidosis, and recovery from acidosis. These signaling events elicit Ca2+-dependent turning behavior, resulting in chemotactic swarming. These results illuminate the bifurcating evolution of sperm underlying the distinct fertilization strategies of this species.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Design and synthesis of some new benzoylthioureido benzenesulfonamide derivatives and their analogues as carbonic anhydrase inhibitors

Khulood H. Oudah, Walaa R. Mahmoud, Fadi M. Awadallah, Azza T. Taher, Safinaz E-S Abbas, Heba Abdelrasheed Allam, Daniela Vullo, Claudiu T. Supuran

Summary: This study reports the design and synthesis of a series of benzoylthioureido derivatives and their screening for carbonic anhydrase inhibitory activity. Some compounds exhibited potent selectivity and inhibitory activity against different CA isoforms. Additionally, molecular docking and ADME prediction studies were conducted to explore the interaction of these compounds with CA isoforms and predict their pharmacokinetics and physicochemical properties.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Schiff bases as linker in the development of quinoline-sulfonamide hybrids as selective cancer-associated carbonic anhydrase isoforms IX/XII inhibitors: A new regioisomerism tactic

Afaf El-Malah, Ehab S. Taher, Andrea Angeli, Samar S. Elbaramawi, Zeinab Mahmoud, Nour Moustafa, Claudiu T. Supuran, Tarek S. Ibrahim

Summary: A series of novel quinoline derivatives with sulfonamide as zinc-binding group (ZBG) were synthesized as carbonic anhydrase (CA) inhibitors. The compounds exhibited efficient inhibition against tumor-associated CA isoforms IX and XII, with one particular hybrid 10b demonstrating significant activity against MCF-7 cancer cells under normal and hypoxic conditions. The compounds also induced apoptosis in MCF-7 and MDA-MB-231 cells and altered the Bax/Bcl expression ratio. Docking studies supported the biological findings, indicating the effectiveness of the regioisomeric tactic for the quinoline-based sulfonamide molecules in inhibiting tumor-relevant hCAs IX/XII.

BIOORGANIC CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Discovery of new 6-ureido/amidocoumarins as highly potent and selective inhibitors for the tumour-relevant carbonic anhydrases IX and XII

Ashraf K. El-Damasy, Hyun Ji Kim, Alessio Nocentini, Seon Hee Seo, Wagdy M. Eldehna, Eun-Kyoung Bang, Claudiu T. Supuran, Gyochang Keum

Summary: A series of 6-ureido/amidocoumarins were designed and synthesised to develop potent and isoform-selective carbonic anhydrase inhibitors. The target coumarins effectively inhibited tumour-related isoforms hCA IX and hCA XII, while not inhibiting cytosolic off-target isoforms hCA I and II. The most promising compound, 3,5-bis-trifluoromethylphenyl ureidocoumarin 5i, showed the best anticancer activity.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Inhibition studies with simple and complex (in)organic anions of the γ-carbonic anhydrase from Mammaliicoccus (Staphylococcus) sciuri, MscCAγ

Simone Giovannuzzi, Viviana De Luca, Clemente Capasso, Claudiu T. Supuran

Summary: The gamma-carbonic anhydrase (CA, EC 4.2.1.1) from Mammaliicoccus (Staphylococcus) sciuri (MscCA gamma) was studied for its inhibition by various (in)organic anions. Peroxydisulfate and trithiocarbonate were the most effective inhibitors, while other anions showed weaker inhibitory effects. Finding more effective MscCA gamma inhibitors could help combat antibiotic resistance.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2023)

Article Endocrinology & Metabolism

Carbonic anhydrases III and IX are new players in the crosstalk between adrenocortical carcinoma and its altered adipose microenvironment

L. Fei, G. Cantini, A. Nocentini, P. Nardini, S. Catarinicchia, L. Canu, T. Ercolino, G. Quartararo, G. Nesi, M. Gacci, M. Maggi, C. Hantel, M. Mannelli, C. T. Supuran, M. Luconi

Summary: This study found that the expression of carbonic anhydrase (CA) enzymes III and IX is altered in obesity and adrenocortical carcinoma (ACC). Specifically, CAIX is upregulated in ACC, while CAIII is downregulated. In vitro coculture experiments showed that CAIX is significantly upregulated in the interaction between ACC and adipose tissue, while CAIII is downregulated. These findings suggest that CA could be a potential target for novel anticancer therapies.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2023)

Article Biochemistry & Molecular Biology

Conformationally Restricted Glycoconjugates Derived from Arylsulfonamides and Coumarins: New Families of Tumour-Associated Carbonic Anhydrase Inhibitors

Monica Martinez-Montiel, Laura L. Romero-Hernandez, Simone Giovannuzzi, Paloma Begines, Adrian Puerta, Ana I. Ahuja-Casarin, Miguel X. Fernandes, Penelope Merino-Montiel, Sara Montiel-Smith, Alessio Nocentini, Jose M. Padron, Claudiu T. Supuran, Jose G. Fernandez-Bolanos, Oscar Lopez

Summary: The development of new inhibitors for carbonic anhydrases (CAs), which are involved in a variety of biological events, is a hot topic in current Medicinal Chemistry. In particular, CA IX and XII, as membrane-bound enzymes, play important roles in tumor survival and chemoresistance. In this study, a bicyclic carbohydrate-based hydrophilic tail was added to a CA-targeting pharmacophore to investigate the influence of tail conformation on CA inhibition.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Membrane Permeability Is Required for the Vasodilatory Effect of Carbonic Anhydrase Inhibitors in Porcine Retinal Arteries

Thor Eysteinsson, Andrea Garcia-Llorca, Arnar Oessur Hardarson, Daniela Vullo, Fabrizio Carta, Claudiu T. Supuran

Summary: Previous research has shown that carbonic anhydrase inhibitors (CAIs) can induce vasodilation in retinal arteriolar segments, but it is unclear which isoforms or mechanisms are responsible for this effect. In this study, four new CAIs that do not enter cell membranes but have high affinity for cytosolic and membrane-bound isoforms of CA were tested. None of these CAIs had a significant effect on arteriolar wall tension, while a membrane permeant CAI called benzolamide fully dilated all segments tested. This suggests that CAIs act as vasodilators through cellular mechanisms located in the cytoplasm of vascular cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Identification of new 4-(6-oxopyridazin-1-yl)benzenesulfonamides as multi-target anti-inflammatory agents targeting carbonic anhydrase, COX-2 and 5-LOX enzymes: synthesis, biological evaluations and modelling insights

Waleed A. A. Badawi, Mahmoud Rashed, Alessio Nocentini, Alessandro Bonardi, Mohammad M. M. Abd-Alhaseeb, Sara T. T. Al-Rashood, Giri Babu Veerakanellore, Taghreed A. A. Majrashi, Eslam B. B. Elkaeed, Bahaa Elgendy, Paola Gratteri, Claudiu T. T. Supuran, Wagdy M. M. Eldehna, Mohamed Elagawany

Summary: In this study, new pyridazine-based sulphonamides were developed as potential multi-target anti-inflammatory drugs, which can inhibit the CA, COX-2, and 5-LOX enzymes simultaneously, avoiding the drawbacks of using NSAIDs alone.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Potent carbonic anhydrase I, II, IX and XII inhibition activity of novel primary benzenesulfonamides incorporating bis-ureido moieties

Tuba Tekeli, Suleyman Akocak, Andrea Petreni, Nebih Lolak, Servet cete, Claudiu T. Supuran

Summary: By conjugating aromatic aminobenzenesulfonamides with aromatic bis-isocyanates, a series of twelve aromatic bis-ureido-substituted benzenesulfonamides was synthesized. These compounds showed effective inhibitory activity against four human carbonic anhydrase isoforms (hCA I, hCA II, hCA IX, and hCA XII), with selectivity towards hCA IX and hCA XII. The inhibition constants of these compounds ranged from 6.73-835 nM against hCA IX and 5.02-429 nM against hCA XII. Given the importance of hCA IX and hCA XII as drug targets for anti-cancer/anti-metastatic drugs, these inhibitors may have significance in cancer-related studies involving these enzymes.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Antihistamines, phenothiazine-based antipsychotics, and tricyclic antidepressants potently activate pharmacologically relevant human carbonic anhydrase isoforms II and VII

Francesco Fiorentino, Alessio Nocentini, Dante Rotili, Claudiu T. Supuran, Antonello Mai

Summary: Carbonic anhydrases (CAs) are important regulators of pH homeostasis and participate in many physiological and pathological processes. This study investigated various drugs as potential CA activators and found that phenothiazine-based antipsychotics and tricyclic antidepressants were the most effective at activating hCA VII. These findings provide insights into the pharmacological profiles of clinically employed drugs and may contribute to the development of novel CA activators.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2023)

Article Chemistry, Multidisciplinary

A new way of synthesizing heterocyclic primary sulfonamide probes for carbonic anhydrase

Vasilisa Krivovicheva, Andrey Bubyrev, Stanislav Kalinin, Dmitry Dar'in, Maxim Gureev, Daniela Vullo, Mikhail Krasavin, Mikhail Korsakov, Claudiu T. Supuran

Summary: An N,N-bis(p-methoxybenzyl)-protected a-acetyl-a-diazo-methane sulfonamide was used as a useful building block for synthesizing new 5-methyl-1,2,3-thiadiazole-4-sulfonamide and methyl 3-sulfamoyl-1H-pyrazole-5-carboxylate. The latter underwent N-alkylation and N-arylation reactions. All resulting compounds exhibited potent inhibition against human carbonic anhydrase I, II, IX, and XII isoforms, particularly the cancer-related forms.

MENDELEEV COMMUNICATIONS (2023)

Article Biology

A Combined in Silico and Structural Study Opens New Perspectives on Aliphatic Sulfonamides, a Still Poorly Investigated Class of CA Inhibitors

Emma Langella, Davide Esposito, Simona Maria Monti, Claudiu T. Supuran, Giuseppina De Simone, Vincenzo Alterio

Summary: Carbonic anhydrases are enzymes involved in an important physiological reaction of converting CO2 to bicarbonate ion. They play crucial roles in various physiological and pathological processes in humans, making them potential targets for therapeutic interventions. This study investigates a class of carbonic anhydrase inhibitors, providing insights into their mechanism of action and potential for drug design.

BIOLOGY-BASEL (2023)

Article Chemistry, Medicinal

Structural Basis of Saccharin Derivative Inhibition of Carbonic Anhydrase IX

Janis Leitans, Andris Kazaks, Janis Bogans, Claudiu T. Supuran, Inara Akopjana, Jekaterina Ivanova, Raivis Zalubovskis, Kaspars Tars

Summary: This study investigates the binding mechanisms between saccharin derivatives and human carbonic anhydrase IX (hCA IX), revealing their unique binding modes and providing insights into the interactions crucial for inhibitor efficacy and selectivity. The findings enhance our understanding of hCA inhibitor binding and inform the rational design of potent agents.

CHEMMEDCHEM (2023)

Article Chemistry, Medicinal

Screening Campaign and Docking Investigations in Identifying New Hit Compounds as Inhibitors of Human Carbonic Anhydrases Expressed In Tumour Cells

Federico Ricci, Andrea Angeli, Francesca Mancuso, Laura De Luca, Claudiu T. Supuran, Rosaria Gitto

Summary: This study reports the discovery of potent inhibitors targeting hCA IX and hCA XII, two isoforms that play a key role in controlling the tumor microenvironment. Through screening arylsulfonamides compounds, two most promising inhibitors were identified with favorable selectivity ratios against other isoforms. Docking studies provided insights into the binding mode of these inhibitors, which can contribute to the development of new sulfonamides as adjuvant agents in cancer management.

CHEMMEDCHEM (2023)

Article Biochemistry & Molecular Biology

Effects of Phosphorylation on the Activity, Inhibition and Stability of Carbonic Anhydrases

Xiaojing Huang, Daniel Winter, Dominic. J. J. Glover, Claudiu. T. T. Supuran, William. A. A. Donald

Summary: Carbonic anhydrases (CAs) are metalloenzymes that play important roles in cellular processes and have been implicated in various diseases. Phosphorylation, a common post-translational modification of CAs, can significantly impact their catalytic activity and drug-binding capabilities. This study highlights the potential regulatory role of phosphorylation in CA activity and its effect on small molecule drug binding.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

No Data Available